Back to Superinvestors
SUPERINVESTOR HOLDERS
MAZE
Maze Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
- Holders
- 2
- Total value
- $33,867,655
- Total shares
- 1,134,975
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Tom Steyer
Farallon Capital Management LLC
|
1,107,814 | $33,057,170 | 0.15% | ADD +734,814 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
27,161 | $810,485 | 0.00% | REDUCE -784 | 30 Jun 2026 |